Diversity in Clinical Trials: The Need to Take Action

Gadi Saarony, CEO of Advarra, examines the current state of diversity in clinical research. He discusses the need for industry to take more action in making trials more diverse, what regulatory bodies need to do to increase awareness, and how researchers can best reach diverse populations.